Home Healthcare Biotechnology mRNA Synthesis Raw Material Market

mRNA Synthesis Raw Material Market Size, Share & Trends Analysis Report By Type (Capping Agents, Nucleotides, Natural Nucleic Acids, Plasmid DNA, Enzymes), By Application (Vaccine Production, Therapeutics Production, Others), By End Use (Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutes) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: January 08, 2026 | Author: Debashree B | Format: | Report Code: SR7741DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. mRNA Synthesis Raw Material Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Capping Agents
      1. CleanCap Reagents
      2. ARCA (Anti-Reverse Cap Analog)
      3. Others
    2. Nucleotides
      1. Modified Nucleic Acids
        1. N1-methylpseudouridine-triphosphate
        2. 5-Methylcytidine triphosphate (5mCTP)
        3. Others
    3. Natural Nucleic Acids
      1. Adenine
      2. Guanine
      3. Cytosine
      4. Uracil
    4. Plasmid DNA
    5. Enzymes
      1. Polymerase
      2. RNase Inhibitor
      3. DNase
      4. Others
  2. mRNA Synthesis Raw Material Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Vaccine Production
    2. Therapeutics Production
    3. Others
  3. mRNA Synthesis Raw Material Market, By End Use 2022-2034 (USD MILLION/ Units)
    1. Biopharmaceutical & Pharmaceutical Companies
    2. CROs & CMOs
    3. Academic & Research Institutes
  4. Regional mRNA Synthesis Raw Material Market
    1. North America
      1. North America mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      2. North America mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      3. North America mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
      4. U.S. mRNA Synthesis Raw Material Market
        1. U.S. mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. U.S. mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. U.S. mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      5. Canada mRNA Synthesis Raw Material Market
        1. Canada mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. Canada mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. Canada mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
    2. Europe
      1. Europe mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      2. Europe mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      3. Europe mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
      4. U.K. mRNA Synthesis Raw Material Market
        1. U.K. mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. U.K. mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. U.K. mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      5. Germany mRNA Synthesis Raw Material Market
        1. Germany mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. Germany mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. Germany mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      6. France mRNA Synthesis Raw Material Market
        1. France mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. France mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. France mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      7. Spain mRNA Synthesis Raw Material Market
        1. Spain mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. Spain mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. Spain mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      8. Italy mRNA Synthesis Raw Material Market
        1. Italy mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. Italy mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. Italy mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      9. Russia mRNA Synthesis Raw Material Market
        1. Russia mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. Russia mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. Russia mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      10. Nordic mRNA Synthesis Raw Material Market
        1. Nordic mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. Nordic mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. Nordic mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      11. Benelux mRNA Synthesis Raw Material Market
        1. Benelux mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. Benelux mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. Benelux mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      12. Rest of Europe mRNA Synthesis Raw Material Market
        1. Rest of Europe mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. Rest of Europe mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. Rest of Europe mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
    3. APAC
      1. APAC mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      2. APAC mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      3. APAC mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
      4. China mRNA Synthesis Raw Material Market
        1. China mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. China mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. China mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      5. Korea mRNA Synthesis Raw Material Market
        1. Korea mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. Korea mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. Korea mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      6. Japan mRNA Synthesis Raw Material Market
        1. Japan mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. Japan mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. Japan mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      7. India mRNA Synthesis Raw Material Market
        1. India mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. India mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. India mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      8. Australia mRNA Synthesis Raw Material Market
        1. Australia mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. Australia mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. Australia mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      9. Taiwan mRNA Synthesis Raw Material Market
        1. Taiwan mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. Taiwan mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. Taiwan mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      10. South East Asia mRNA Synthesis Raw Material Market
        1. South East Asia mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. South East Asia mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. South East Asia mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      11. Rest of Asia-Pacific mRNA Synthesis Raw Material Market
        1. Rest of Asia-Pacific mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. Rest of Asia-Pacific mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. Rest of Asia-Pacific mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
    4. Middle East and Africa
      1. Middle East and Africa mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      2. Middle East and Africa mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      3. Middle East and Africa mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
      4. UAE mRNA Synthesis Raw Material Market
        1. UAE mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. UAE mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. UAE mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      5. Turkey mRNA Synthesis Raw Material Market
        1. Turkey mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. Turkey mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. Turkey mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      6. Saudi Arabia mRNA Synthesis Raw Material Market
        1. Saudi Arabia mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. Saudi Arabia mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. Saudi Arabia mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      7. South Africa mRNA Synthesis Raw Material Market
        1. South Africa mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. South Africa mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. South Africa mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      8. Egypt mRNA Synthesis Raw Material Market
        1. Egypt mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. Egypt mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. Egypt mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      9. Nigeria mRNA Synthesis Raw Material Market
        1. Nigeria mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. Nigeria mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. Nigeria mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      10. Rest of MEA mRNA Synthesis Raw Material Market
        1. Rest of MEA mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. Rest of MEA mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. Rest of MEA mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
    5. LATAM
      1. LATAM mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
        1. Capping Agents
          1. CleanCap Reagents
          2. ARCA (Anti-Reverse Cap Analog)
          3. Others
        2. Nucleotides
          1. Modified Nucleic Acids
            1. N1-methylpseudouridine-triphosphate
            2. 5-Methylcytidine triphosphate (5mCTP)
            3. Others
        3. Natural Nucleic Acids
          1. Adenine
          2. Guanine
          3. Cytosine
          4. Uracil
        4. Plasmid DNA
        5. Enzymes
          1. Polymerase
          2. RNase Inhibitor
          3. DNase
          4. Others
      2. LATAM mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
        1. Vaccine Production
        2. Therapeutics Production
        3. Others
      3. LATAM mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Biopharmaceutical & Pharmaceutical Companies
        2. CROs & CMOs
        3. Academic & Research Institutes
      4. Brazil mRNA Synthesis Raw Material Market
        1. Brazil mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. Brazil mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. Brazil mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      5. Mexico mRNA Synthesis Raw Material Market
        1. Mexico mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. Mexico mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. Mexico mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      6. Argentina mRNA Synthesis Raw Material Market
        1. Argentina mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. Argentina mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. Argentina mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      7. Chile mRNA Synthesis Raw Material Market
        1. Chile mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. Chile mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. Chile mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      8. Colombia mRNA Synthesis Raw Material Market
        1. Colombia mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. Colombia mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. Colombia mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
      9. Rest of LATAM mRNA Synthesis Raw Material Market
        1. Rest of LATAM mRNA Synthesis Raw Material Market By Type 2022-2034 (USD MILLION/ Units)
          1. Capping Agents
            1. CleanCap Reagents
            2. ARCA (Anti-Reverse Cap Analog)
            3. Others
          2. Nucleotides
            1. Modified Nucleic Acids
              1. N1-methylpseudouridine-triphosphate
              2. 5-Methylcytidine triphosphate (5mCTP)
              3. Others
          3. Natural Nucleic Acids
            1. Adenine
            2. Guanine
            3. Cytosine
            4. Uracil
          4. Plasmid DNA
          5. Enzymes
            1. Polymerase
            2. RNase Inhibitor
            3. DNase
            4. Others
        2. Rest of LATAM mRNA Synthesis Raw Material Market By Application 2022-2034 (USD MILLION/ Units)
          1. Vaccine Production
          2. Therapeutics Production
          3. Others
        3. Rest of LATAM mRNA Synthesis Raw Material Market By End Use 2022-2034 (USD MILLION/ Units)
          1. Biopharmaceutical & Pharmaceutical Companies
          2. CROs & CMOs
          3. Academic & Research Institutes
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.